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Background: The monitoring and evaluation of health research capacity strengthening (health RCS) commonly
involves documenting activities and outputs using indicators or metrics. We sought to catalogue the types of
indicators being used to evaluate health RCS and to assess potential gaps in quality and coverage.
Methods: We purposively selected twelve evaluations to maximize diversity in health RCS, funders, countries, and
approaches to evaluation. We explored the quality of the indicators and extracted them into a matrix across individual,
institutional, and national/regional/network levels, based on a matrix in the ESSENCE Planning, Monitoring and Evaluation
framework. We synthesized across potential impact pathways (activities to outputs to outcomes) and iteratively checked
our findings with key health RCS evaluation stakeholders.
Results: Evaluations varied remarkably in the strengths of their evaluation designs. The validity of indicators and potential
biases were documented in a minority of reports. Indicators were primarily of activities, outputs, or outcomes, with little
on their inter-relationships. Individual level indicators tended to be more quantitative, comparable, and attentive to equity
considerations. Institutional and national–international level indicators were extremely diverse. Although linkage of
activities through outputs to outcomes within evaluations was limited, across the evaluations we were able to construct
potential pathways of change and assemble corresponding indicators.
Conclusions: Opportunities for improving health RCS evaluations include work on indicator measurement properties and
development of indicators which better encompass relationships with knowledge users. Greater attention to evaluation
design, prospective indicator measurement, and systematic linkage of indicators in keeping with theories of change could
provide more robust evidence on outcomes of health RCS.
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The need for all countries to generate and use health re-
search in order to inform practice and policy decisions
has become increasingly accepted over the last decade
[1]. However, there remain gaps in the production of
health research, particularly in many low- and middle-
income countries (LMICs) [2]. Profiles to assess LMIC
capacity for equity-oriented health research have been
developed [3], resources assembled for health research
capacity strengthening (RCS) [4], and ways forward pro-
posed by leading African health researchers [5] and
health systems organizations [6,7]. RCS has been defined* Correspondence: donald.cole@utoronto.ca
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unless otherwise stated.as a “process of individual and institutional development
which leads to higher levels of skills and greater ability to
perform useful research” [8]. Experience has accumulated
among those engaged in RCS for development in general
[9], including case studies of health RCS [6], yet the het-
erogeneity and complexity of health RCS initiatives have
hindered systematic assessments of effectiveness [10]. As
one author has noted, “We are at the early stages of
knowing how best to identify, target and affect the many
factors that are important for stronger research capacity.
Furthermore, as RCS initiatives become more wide-ranging
and complex, they become more difficult to monitor and
evaluate.…. There is a clear need for improved strategies
and the development of a tried and tested framework for
RCS tracking” [11].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Cole et al. Health Research Policy and Systems 2014, 12:17 Page 2 of 13
http://www.health-policy-systems.com/content/12/1/17Organisations that fund and manage research capacity
strengthening initiatives, both nationally, e.g., the UK Col-
laborative on Development Sciences [9], and internationally,
e.g., the ESSENCE on Health Research Initiative [12], have
responded by collaborating to identify common issues relat-
ing to evaluating RCS programmes. Critical to making sense
of RCS outcomes is the need to be explicit about the path-
way by which change is to be brought about, i.e., the theory
of change [13]. Indicators of the steps along the pathway
from activities through outputs to outcomes can be linked
within frameworks for evaluation of health RCS [14].
Currently, indicators or metrics are in widespread use in
health programmes to monitor performance, measure achie-
vement, and demonstrate accountability [15]. Generally ac-
cepted criteria for development evaluation involve use
of Specific, Measurable, Attainable, Realistic and Timely
(SMART) indicators [16]. Research impact evaluators have
suggested including indicators not only of knowledge pro-
duction and capacity development, but also of changes in
health system policies, programs, and practices [17].
In the research reported here, we investigated reports of
health RCS evaluations held by funders as a potentially
rich source of untapped information. Our objective was to
describe the design of health RCS evaluations, the nature
of the indicators used, and the linkages among activities,
outputs, and outcomes. We sought evidence to underpin
the design of rigorous health RCS evaluations and the
choice of indicators to be used for tracking progress and
impacts, in ways which can transparently demonstrate
value to all health RCS stakeholders – funders, research
organizations, researchers, trainees, and research users.
Methods
We adopted a qualitative approach to report identification,
evaluation quality appraisal, indicator extraction, and syn-
thesis. We consulted with stakeholders from LMIC health
research funding agencies as part of a knowledge user ori-
ented process [18]. Formal approval was obtained from
the University of Toronto Health Sciences Research Ethics
Board (#26837).
Report identification
Our experience in reviewing proposals for health RCS,
conducting and evaluating it, and searching the peer-
reviewed literature led us to expect evaluations of a
range of initiatives, from discreet projects, through port-
folios of projects, to integrated long-term programmes.
We initially consulted with funding agency members of
the ESSENCE on Health Research initiative regarding re-
port availability. Using a snowballing process, we invited
other funders of LMIC research, known to support health
RCS, to contribute health RCS evaluation reports. Eleven
of 31 funding agencies contacted agreed to provide such
reports, from which two authors agreed upon 54 reportsof relevant health RCS evaluations that were publicly avail-
able, written in English, and produced since 2000. Each re-
port was read by a pair of reviewers to assess the type of
health RCS, funders, countries, detail available [19], and
approach to evaluation. Sometimes more than one report
was involved in evaluation of a health RCS initiative. Ap-
plying maximum variety sampling [20], we purposively se-
lected 18 reports of 12 evaluations.
Quality appraisal
Because of the growing emphasis on evidence of effect-
iveness, we appraised the quality of the evaluations. We
derived the following quality appraisal questions from
the Development Assistance Committee standards [16]
and applied them to each evaluation report:
 Was the purpose of the evaluation clearly stated?
 Was the methodology described (including the
analysis)?
 Were the indicators made explicit and justified?
In the methodology, we were particular interested in de-
sign, indicator measurement and collection, and bias. Our
appraisal of the quality of indicators mentioned in the reports
drew from SMART criteria (p10, Sn 2.9 of OECD standards)
[16]. Two reviewers appraised each evaluation independently,
providing brief justifications for their appraisals.
Indicator extraction
We conducted a systematic framework analysis on the
evaluation reports [21], extracting text relating to indica-
tors used, and the context of that use. Many reports con-
tained narrative descriptions of an activity, output, or
outcome, which implied the nature of a corresponding in-
dicator, while fewer explicitly defined indicators. Both
descriptions and definitions were extracted and coded ac-
cording to the categories in the ESSENCE Planning,
Monitoring and Evaluation matrix [12] or to new cate-
gories that emerged. In order to promote learning and
consistency in the extraction process, members of the re-
search team each coded at least three reports, published
by at least two funders, and relating to at least two evalua-
tions, with each report being coded independently by two
researchers. Discussion on coding of a smaller initial set
fostered a common approach prior to coding all reports.
Two authors independently extracted text from each
evaluation report, checking consistency and resolving dis-
crepancies through discussion, if necessary, by bringing in
a third reviewer. We stopped when no new insights
emerged from analysis of additional reports.
Synthesis
We reviewed extracted material and created additional
categories as needed. Given the importance of pathways
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tify and document links between aims and indicators and
from activities through to outputs and outcomes. Clear
descriptions of these links were unfortunately rare within
any one evaluation. Therefore, we brought together exam-
ples of indicators and their contexts from several different
evaluations, in order to illustrate the potential for such
linkages. At several stages throughout the project our in-
terim findings were discussed with the ESSENCE on
Health Research initiative steering committee. Their feed-
back helped us to focus our analysis, and to validate and
interpret our results [22].
Results
The 12 evaluations were of health RCS initiatives covering
the wide range we had expected. They were of different
durations, conducted by different kinds of evaluators, at
different stages of the initiative, and using a variety of
evaluation approaches (Table 1) [23-40].
Quality of the health RCS evaluation designs
All evaluations had clear statements of their purpose
or objectives, often with explicit terms of reference
appended to the reports (see Quality Appraisal of Evalu-
ations – Illustrative Examples below). Most evaluations
used mixed method designs and drew on existing data
or prior reports, often supplemented with site visits and/
or interviews. The degree of complexity of the various
evaluations reflected the complexity of the health RCS
initiative; for example, the design of an evaluation con-
cerning individuals in scholarship programs [23,24] was
simpler than that used to evaluate changes in health eco-
nomics capacity across an entire region [37]. Variability
in evaluation design also related partly to the stage of
the evaluation: a review early in the project cycle [27]
was less complex than that of a long-running program
undergoing a final stage review [38,39]. Several evalua-
tors were constrained by the lack of a clear monitoring
and evaluation framework [25], to help them orient their
observations, and by the short time frame allowed for
their review [26]. Though some reports were able to use
historical comparisons [38,39], the majority were not
able to draw on any baseline data [29-32], and only one
evaluation considered (but did not use) a ‘control’ com-
parison [33]. These constraints limited assessment of
change, its attribution to the health RCS programme,
and potential estimates of effectiveness.
Quality appraisal of evaluations – illustrative examples
Purpose of evaluation clearly stated
 To assist with the improvement of future development
activities; to place tropical disease research in the
existing landscape of health RCS [38,39]. To appraise Swedish International Development
Agency’s support to capacity building in the
sub-Saharan Africa region. The most important
purpose from the evaluators’ point of view was to
provide stakeholders with the opportunity to learn
about and develop the ongoing project [37].
 To assess implementation and preliminary
outcomes, focusing on awardees careers; to guide a
future outcome evaluation [34].
 To assess European and Developing Countries
Clinical Trials Partnership (EDCTP) programme
performance, including economic, social, and
environmental impacts; address the role of EDCTP
in the broader international research and
development agenda; learn lessons and make
recommendations for future initiatives [28].
Explicit evaluation design
 A feasibility study, including pilot tests, guided the
evaluation survey design [33].
 Quantitative analyses of deliverables and a
qualitative analysis of the process, perceived
outcomes, and effects at regional, national, and
institutional levels [38,39].
 Broad focus on all health-related alumni and impact
of awards; in-depth focus on selected case studies
and five alumni [23,24].
Data collection clearly described and validity checked
 Used qualitative interview recording, transcribing,
and thematic coding. A self-assessment tool was
used for research competency but its provenance
was not explained [38].
 Interviews to solicit information on factors
influencing post-grant careers; interviewees selected
to balance gender, research interest, and nationality [38].
 Online surveys for awardees and unsuccessful
applicants [34].
 Validity ensured by multiple data sources, triangulation,
site visits, wide discussions to corroborate and validate
information, and an iterative process throughout the
evaluation [35,36,38-40].
Indicators explicit and justified
 Each bibliometric indicator provided insights into
research quality, i.e., quantity of papers, citation
rates, impact factor; norm-referencing [33].
 Indicators were stipulated in an evaluation
framework and designed with stakeholders using
intervention logic [40].
Table 1 Characteristics of international funders’ evaluations of LMIC health research capacity strengthening (RCS)
Evaluations by
international funder
Health RCS characteristics Relation of evaluator to funder Evaluation characteristics
Project, programme(s),
organisation
Period (duration) covered
by the evaluation
Timing M proaches/methods
ACU-CSC [23,24] RCS programme – with
streams, health sector
1960+ (48 years) Funder staff Periodic review A of existing award data, alumni evaluation
s 15 case studies, and 5 telephone interviews
o ted scholarship recipients; impact assessment.
Carnegie [25] RCS initiative with networks 2008–2010 (2 years) Contract evaluation organisation Mid-term D view or initiative and network documents,
i s and focus groups with stakeholders
( ff and students within each network).
Danida [26] Health research programmes
of which health RCS is a part
1997–2006 (10 years) Contracted evaluation organisation Periodic review C nents were: a) country reports with visits;
b study review of projects; c) institutional
q naires for Danish research groups; d) ‘internal’
[ organisations] individual staff questionnaires;
e nal’ [non-Danish other HIC funder] questionnaires
a rviews; f) literature review of publications
s ed; g) evaluation document analysis; and
h h-related project database analysis.
DfID [27] Project Health research
council
2008–2010 (2 years) External programme evaluation team Mid-term review D view of organisational, programme, and project
d ntation; site visit with interviews of stakeholders,
b aries, non‐beneficiaries, funders, and secretariat;
i case studies of selected grantees and their
i ns; and evaluation of the grants selection process.
EDCTP [28] Health research partnership 2007–2009 (2 years) Independent external panel Periodic review D ntation analysis, meetings/discussions and
i s with organisational representatives, questionnaire
s f researchers, site visit, conference attendance
a ntry case study.
IDRC [29-32] Health research programme
with projects
Roughly 2001–2008 (7 years) Contracted evaluation team Special review C ted a gender audit at three levels – institutional,
p matic, and project (review of 15 projects) – through
d ntation review; search of guidelines and strategies
o organisations working on policy, health and gender
i eview of a previous internal gender survey; gender
q naire to assess capacity development needs; and
i al interviews with funder staff.
NIH-FIC (1) [33] Health RCS programme 1992–2003 (11 years) Contract evaluators Periodic review O e evaluation using NIH-FIC evaluation framework
a CA logic model. Administrative data collection and
r interviews with programme stakeholders, census
s of the US principal investigators and international
r collaborators, bibliometric analysis of publications,
a visits.
NIH-FIC (2) [34] Health RCS programme 2002–2008 (6 years) Contract evaluation team Mid-term review P me implementation and preliminary outcomes. Data
c n methods included two online surveys (GRIP awardees,
u ssful applicants with scored applications). Supplementary
d administrative sources and databases, MEDLINE, and
f erviews with US-based mentors, FIC staff members, and
p me partners.
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Table 1 Characteristics of international funders’ evaluations of LMIC health research capacity strengthening (RCS) (Continued)
NWO/WOTRO [35,36] Health RCS & health
research programmes
2005–2008 (4 years) (2008) Committee of three experts
& two secretariat members (2009)
Contract evaluators
Mid-term review (2008) Background document review, discussions with
programme coordinators, site visits with interviews, formulate
recommendations, and discuss with Programme Committee.
(2009) Not specified but included: programme document
review, programme logic construction, projects’ progress
reports analysis, and stakeholder interviews.
Sida [37] Linked health RCS project
funding (three routes)
1999–2005 (6 years) Contract evaluators Mid-term for re-formulation Emailed questionnaires to institutions, individuals, and
graduates. Interviews during site visits and evaluation
seminar at main site.
TDR –WHO [38,39] Organisation’s entire set of
health RCS programmes
2000–2008 (9 years) Contracted institute evaluation team Periodic review Questionnaires (individuals, research groups, and institutions),
selected in-depth interviews, institutional site visits with
stakeholder semi-structured interviews.
Wellcome trust [40] Health RCS project –
Consortium
2009–2011 (2 years) Contract evaluation organisation Mid-term (Second annual) Real-time, monitoring and evaluation with mutually agreed
framework of qualitative and quantitative indicators. Analysis
in the light of all consortia within the programme of which
this project is a part.
ACU-CSC, Association of Commonwealth Universities – Commonwealth Scholarship Commission (UK); Carnegie, Carnegie Corporation of New York through Science Initiative Group; Danida, Development cooperation
activity, Ministry of Foreign Affairs (Denmark); DfID, Department for International Development (UK); EDCTP, European and Developing Countries Clinical Trials Partnership; ESSENCE, Enhancing Support for
Strengthening the Effectiveness of National Capacity Efforts on Health Research Initiative; FIRCA, Fogarty International Research Collaboration Awards; GRIP, Global Research Initiative Program; HIC, High income country
(ies); IDRC, International Development Research Centre (Canada); LMIC, Low- and middle-income countries; NIH-FIC, National Institutes of Health – Fogarty International Center (USA); NWO/WOTRO, Science for Global
Development, Netherlands Organisation for Scientific Research; Sida, Swedish International Development Agency; TDR/WHO, Tropical Disease Research – World Health Organization.
C
ole
et
al.H
ealth
Research
Policy
and
System
s
2014,12:17
Page
5
of
13
http://w
w
w
.health-policy-system
s.com
/content/12/1/17
Cole et al. Health Research Policy and Systems 2014, 12:17 Page 6 of 13
http://www.health-policy-systems.com/content/12/1/17 Evaluation used EDCTP’s indicators, but limited by
absence of any a priori formulated measurable
indicators for the expected outcome set at the start
of the programme [28].
Biases and limitations discussed
 The lack of a uniform monitoring and evaluation
framework and reporting system resulted in
collection of different types of data, and therefore
different insights and conclusions [25].
 Limitations of using a self-assessment survey [25, p. 14]
and the subjectivity of the evaluations and learning [40].
 Variables (e.g., linguistic, internet access) and
potential biases in responses, recall, and
classification were taken into account [33].
 The reasons for limited responses and the possibility
of response bias were noted [34,37].
 Consideration was given to the feasibility of a
comparative evaluation design and the need for longer-
term and more rigorous design to assess outcomes and
impact of Global Research Initiative Program [34].
 Unavailability of original documentation
[23,24,29-32].
 Lack of pre-determined measurable indicators and
independently verifiable data necessitated an
opinion-based retrospective evaluation [28].
The evaluations surveyed individual grantees, institu-
tional representatives, or relevant key informants at na-
tional and international levels. Questionnaires were all
crafted specifically for the evaluation, i.e., no existing instru-
ments with known properties or prior validation were used,
yet only one evaluation report describing a formal pilot to
test the questionnaire was used [33]. Half of the evaluations
explicitly addressed potential biases or other threats to the
integrity of the evaluation, with some noting low response
rates. Some cited the importance of site visits and other
means to triangulate reports from grantee respondents, and
a few described iteratively re-visiting different groups to ob-
tain feedback on their emerging findings.
Indicators used for tracking progress in health RCS
initiatives
The extent of indicator description and depth of justifica-
tion for the choice of indicators varied widely between
evaluation reports. Indicators were often linked to specific
objectives, attainable and realistic for the programme, and
many were timely for programme monitoring (SMART cri-
teria). Developing indicators that were ‘measurable’ seemed
to be more of a challenge. Some reports referred to “meas-
uring progress using testable goals – relevance, governance,
efficiency and effectiveness” [23], but did not provide an ex-
plicit definition of these terms. A few evaluations didinclude indicators which involved considerable measure-
ment work, e.g., on bibliometric indicators of the quality of
research performed by grantees [33]. Other evaluations ex-
plicitly linked indicators to intervention logic frameworks
(see Quality Appraisal of Evaluations – Illustrative Exam-
ples above). Although no single evaluation provided enough
information to enable us to describe an explicit pathway of
activities to outputs and outcomes, it was possible to link
common indicators across evaluations. Specific examples
follow to illustrate the context in which the indicators were
used at different levels.
Individual level indicators
Indicators relating to training in research skills for re-
searchers and also other personnel, such as data man-
agers and laboratory staff, were common (see Table 2).
Indicators of training in areas relevant to professional
skills (e.g., research management) and of training quality
(e.g., PhD education) meets international standards [40]
and researcher/student satisfaction, were noted in some
reports [34-36].
Some reports included indicators that assessed equal-
ity of award allocation by utilising data which had been
disaggregated by gender, nationality, country income
level, discipline, and level of award [34,38,40]. One
evaluation specifically focused on how gender-related in-
dicators could become more part of research funding,
training, and reporting [29]. Other equity-related disag-
gregations, e.g., by socio-economic status within the
country or potentially excluded groups, such as ethnic
minorities or aboriginal peoples [16], were only apparent
in one evaluation [28, p. 85]. From a North–South
equity perspective, one evaluation noted “Most project
coordinators and project leaders or principal investiga-
tors are African researchers (55.5%), with good represen-
tation of female researchers: 40% in AIDS projects and
25% in TB and Malaria projects” but the benchmark for
such judgements was not clear [28].
Some evaluations included indicators for trainee men-
toring, noting low mentor to trainee ratios, with intense
competition for senior supervisors among the many re-
search projects funded by international donors [34]. Job
outcome indicators were pertinent to several health RCS
activities and were very much affected by context, e.g., the
lack of career opportunities/structures for post-doctoral
students resulting in a high proportion of PhD graduates
not continuing active research careers [35,36].
Institutional level indicators
Several evaluations linked support for individual grantees
to institutional research strengthening [35,36,40]. Others
retrospectively analysed funding allocations according to
location and characteristics of the recipient institutions
[34]. Indicators used in an evaluation of a PhD and MSc
Table 2 Potential pathways to change: indicators of outputs and outcomes linked to activities primarily at the
individual level
Research skills training activities: PhDs, MScs, scholarships, fellowships, and salary supplementation. Training of research support staff, i.e., data
managers, research laboratory personnel, statisticians, and research managers.
Outputs Outcomes
Feedback from recipients about career prospects. Development of research skills, i.e., identification of a research problem,
analytical review of a scientific article, research proposal, and scientific
report writing.Quality of training.
Balance between training in research methods (i.e., protocol, methods,
collection and analysis), research process (i.e., writing, communication,
knowledge transfer), and advocacy, promotion, negotiation, and
resource mobilisation.
Quantitative and qualitative evidence of the effectiveness of the awards
(from survey about careers, achievements, and impact).
Evidence that awardees returned to active and independent research in LMICs.
Reasons why trainees did not return/stay in LMICs (e.g., poor career prospects;
no opportunity to use skills).
Development of sustainable research collaborations.
For HIC researchers, improved understanding of international research
issues and increased desire to collaborate with researchers in
developing countries.
New research funding obtained.
Mentoring activities: Individual support for developing skills in research and supervision.
Outputs Outcomes
Number of trainees with a mentor. Number of grantees working as senior researchers and their location
(e.g., academia, in government agencies, or private sector).
Knowledge of reasons for lack of career development, i.e., lack of
resources, supervision, and collaborators. Percent of time spent on research activities.
Scientific conference and workshop activities: Health Economics Conference, EDCTP Forum, networking, sharing with colleagues, and policy makers.
Outputs Outcomes
Number of meetings/workshops attended pre- and post-funding. Research by awardees published in conference proceedings.
Invitations to speak at meetings. Honours, awards, esteem, expanded
social networks.
Membership and/or leadership role (e.g., president, chair, secretary, editor)
in professional societies, advisory groups or scientific journal.
Course and curricula development activities: Short courses/diplomas/degrees in research skills and methods, and scientific topics developed in
response to a needs assessment and embedded within the university.
Outputs Outcomes
Partnerships used for course design, student supervision, mentoring, and
bilateral recognition of credits.
Secondary benefits to students through training, travel and education
opportunities made them ‘diffusers’ of new techniques between institutions.
Courses (e.g., masters, PhD) run by university consortia promoted
relationships between universities and/or across specialities
(e.g., health economics).
Database of courses; attendance register.
EDCTP, European and Developing Countries Clinical Trials Partnership; HIC, High income country; LMIC, Low- and middle-income countries.
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guidance on criteria for student selection and a lack of
linkage between training support and engagement in re-
search [35,36]. Other indicators focused on the institu-
tional capacity to mentor more junior researchers (as
distinct from supervision of research students), to help
returning graduates start research (e.g., an improved infor-
mation and communication technology system to facilitate
communications with colleagues globally), and to support
active investigators (Table 3).
Indicators related to research infrastructure and manage-
ment activities focused on ‘hard’ infrastructure (e.g., libraries,lab equipment) and ‘softer’ systems (e.g., implementation of
new routines, policies, resource allocations and systems of
compensation [37], leadership of funding proposals to at-
tract research funding and implement and manage research
[35,36], and the development of organisational learning
mechanisms) [33]. A few evaluations highlighted missed op-
portunities such as the limited sharing of donated equip-
ment, materials, and techniques [35,36]. Indicators of
institutional collaborations used in some evaluations in-
cluded local ownership [26], regional partnerships [26,27],
and enhanced visibility of the institution in the national and
international research communities [34].
Table 3 Potential pathways to change: indicators of outputs and outcomes linked to activities primarily at the
institutional level
Human resources strengthening activities: Staff training and recruitment (e.g., data management, laboratory scientists), including salaries.
Strengthening inter-staff and inter-student relationships. Promoting inter-disciplinarity, diversity, and specialization.
Outputs Outcomes
Numbers of potential supervisors. Recruitment and retention of researchers, supervisors, and core staff.
Capacity to mentor junior researchers, take on
leadership and inspirational roles. Clear research career paths/possibilities.
Institutional destination/return home of researchers and graduates. Involvement of research managers in the collaboration/network.
Activities for strengthening research infrastructure and management: Support for infrastructure (e.g., laboratory facilities, equipment, and
maintenance; libraries, IT, computers). Setting up ethical review boards, engagement of stakeholders and secretariats. Improved governance,
planning, strengthening of financial reporting, institutional evaluation capacity, and gender analysis.
Outputs Outcomes
Establishment of cross-cutting projects, sharing of equipment (e.g., fridge,
freezer, thermocycler, microscopes, centrifuge, and computer), staff
(e.g., lab technicians), and systems (e.g., data management) facilitates
integration of research activities.
Better access to resources (e.g., staff, libraries, journals, equipment).
Research staff satisfied with institution’s research services (i.e., workplace,
library, internet access, journal access, lab facilities, purchasing system,
maintenance, human resources).
Standard operating procedures, quality assurance mechanisms.
Improved management and administrative capacity and technical capacity
(e.g., for lab quality control, trial monitoring services, data management, and
data analysis support).
A research support centre, scientific steering committee, institutional
governance structure, and organisational chart.
Commitment to or implementation of strategic
planning, management, new policies, resource allocations. Achievement of international accreditation, e.g., of laboratories able to
attract private funding as well.
Evidence of a transferable partly self-sustaining model (salaries externally
supported) for Research Support Centre.
Scientific collaboration activities: Promotion of collaborations for North–South and South-South and/or regional partnerships, sometimes restricted
to existing grantees, or projects led from the South.
Outputs Outcomes
Formal agreements, including for data sharing. Collaborations characterised by trust and commitment, and continue after
award concludes.
Site inspections, meetings together.
Joint PhD students, projects, and technologies shared between collaborators. Benefits for northern institutions (i.e., understand LMICs health system,
engage with research and training institutions).
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Indicators of activities with national policy makers, re-
gional organizations, or networks captured components
of the system in which individual and institutional health
RCS were embedded (Table 4) [6,14]. Stakeholder en-
gagement and research uptake indicators included sys-
tematic identification of potential users of research for
early engagement [34,40], a comprehensive communica-
tion strategy [40], and appropriate tailor-made tools for
dissemination of research [33,38]. Indicators of the cap-
acities of research users and policy makers to utilise re-
search information were rare but included skills in
acquiring research information, assessing its quality, and
using it for decision-making [37]. Involvement of non-
scientific communities was used as an indicator of em-
bedding research partnerships within public health
structures [37]. Important indicators of national research
capacity were the commitment of Ministries of Health
to research and the development of national researchcouncils with explicit national research priority-setting
processes and legal frameworks for research [27,34].
Development of trans-disciplinary platforms and net-
works of researchers or institutions were key indicators
of the ability to assemble a critical mass of researchers
[26,27,40]. The promotion of the financial sustainability
of research capacity within a country or region, some-
times through involvement of private partners, was an-
other indicator [34]. Network leaders were identified as
graduates from previously funded programmes, a long
term indicator of one programme’s impact [34]. An indi-
cator of stability of co-operation across partner institu-
tions was lack of dependence on specific individuals in a
context of high personnel turnover [26,34]. Whether a
network was dysfunctional or smoothly run, whether
feelings of injustice and insecurity were developing [26],
and the existence of rules around ‘competition-collabor-
ation’ [34] were all indicators of the quality of network
functioning. One evaluation of a programme which
Table 4 Potential pathways to change: indicators of outputs and outcomes linked to activities primarily at the
national-international level
Engagement and communication activities for research uptake: Engagement with private and non-health organisations, NGOs, HIV programmes,
research institutions, health ministries, regulatory authorities. Using journals, press, magazines, conferences/workshops, networks, face-to-face interaction,
websites, consensus reports, policy briefs, newsletters.
Outputs Outcomes
Skills development program from public-private-academic partnerships. Advocacy resulted in enhanced health RCS effort, or enhanced knowledge
about neglected topic diseases (e.g., fish-borne zoonotic parasites).
Systematic plan for acquiring and using research information, and for
sharing and transferring knowledge. Knowledge about focus of health RCS efforts – tend to be more on
researchers and less on research users.
Media articles (i.e., press, magazines, reports, website). Partnerships for research dialogue (e.g., with policymakers, research users,
decision makers national authorities, professional groups, private sector,
NGOs, civil society) at local, regional, and international levels.Communication/knowledge management strategy
Trends in website hits.
Activities to develop national health research systems or scientific councils: Promote financial sustainability in regional research activities.
Outputs Outcomes
Map of national research system. Strong commitment and active engagement by national health research
institutions and health ministries to review progress and determine
research priorities.
Knowledge about contribution (or not) of national agencies to development
of effective national health research system and in creating demand for research.
External funds provided more accessibility and flexibility than local funds.
Networking activities for researchers and/or research users: Facilitation of collaborations and large-scale networks, sometimes through
multi-disciplinary workshops, curricula, meetings, and seminars.
Outputs Outcomes
New programme and partnership for research to strengthen links between
universities and policy making (e.g., systematic reviews for research).
Impact on policy, practice, and knowledge at different levels (i.e., international,
regional, national, district level) and on health and non-health sectors, through
research and policy networks.
Project staff contributed to evaluations of health centres and systems
and to motivating medical staff.
Estimated impact on disease control and prevention.
Harmonised regional research activities.
North–South and South–South networking activities.
Active committees with institutional representation in each member
country.
Commitment and communication with the Northern and among
Southern partners.
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not have information ‘at their fingertips’ and some could
not obtain output level data. It urged the use of a more
formal monitoring and evaluation framework grounded
in each individual programme’s theory-in-use and pro-
gram logic [26].
Discussion
Indicator coverage
Our systematic analysis of diverse international health
research funders’ evaluations uncovered a broad set of in-
dicators including metrics available to measure return on in-
vestment in health research [17]. Many of the evaluations
used a subset of indicators among those identified by the
ESSENCE on health research initiative including curricula
developed, courses run, researchers trained, scientific colla-borations initiated, and partnerships strengthened. Given
the global focus on health equity [41], the rarity of disaggre-
gation of indicator data according to equity categories was
concerning. The Ford Foundation’s work on active recruit-
ment of those from disadvantaged backgrounds [42], and
NIH-FIC’s Career Track’s inclusion of ‘minority type’ (Celia
Wolfman, personal communication) hold promise.
Missing in the evaluations were some important con-
structs relevant to health RCS, particularly ongoing rela-
tionships among RCS stakeholders to facilitate conduct
and use of research [43]. Further, nomenclature was
highly variable for the national/international level –
terms included societal, macro, environment, and net-
work, perhaps reflecting the systems nature of much
health RCS [44]. Use of the term ‘local’ to describe that
which is not global is not particularly helpful in thinking
about the scale of health RCS efforts, as it can refer to
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tricts, provinces or regions within a country, and nations
to multi-country regions, e.g., East Africa. Greater atten-
tion should be paid to clarifying scale, perhaps separating
out three components – provincial-national research en-
vironment, international-global research environment,
and research networks – in order to facilitate greater clar-
ity of relationships between indicators and consistency in
cross case comparisons [6,7].
Indicator quality
Comments on quality of indicators were rare, despite
Development Assistance Committee standards, and only
a few individual indicators met most of the SMART cri-
teria [16]. The quality challenges may reflect the division
of responsibility for collecting indicator-related data
among funders, institutions and researchers implement-
ing health RCS, and evaluators. They may also reflect
the limited investment of time and resources in evalua-
tions, relegating them to more of a milestone monitoring
role than a key ingredient for determination of equity,
effectiveness, or efficiency. Each stakeholder may be in-
terested in different indicators on account of their differ-
ing roles in assessing research impact [45]. Stakeholders
should therefore be involved in early planning regarding
the selection and quality of indicators to be used [46].
Health RCS contribution assessment
Virtually all evaluations were retrospective in nature,
with only a few [33,40] engaging in the kind of forward
planning to promote applicability of indicator selection
over time and rigour of evaluation designs [46]. Few
evaluations systematically considered assumptions, pre-
conditions, or measurement challenges, confounders or
co-interventions, all of which are needed to clarify caus-
ality. Explicit use of theories of change [13] with delinea-
tion of pathways linking indicators within explicit
frameworks [14] was rare, perhaps because of the limited
attention to mechanisms by which health RCS initiatives
might effectively address problems identified and bring
about the hoped-for changes [46]. Such gaps undercut
assessment of the contribution of health RCS pro-
grammes to longer term impacts [47].
Limitations of our study
Not all health RCS funders whom we approached pro-
vided reports. Further, we could not undertake detailed
analysis on a large number of evaluations due to the
labour intensive nature of data extraction and analysis.
Nevertheless, the evaluations we did analyse covered a
broad range of countries, types of health RCS initiatives,international funders, and contexts. Many common
themes emerged during our analysis, particularly later in
our analysis process, as we reached saturation, suggest-
ing that incorporating additional evaluations would not
yield substantially new information. Allocation of ex-
tracts from evaluation narratives and indicators to the
various framework analysis categories was occasionally
only resolved through discussion. Most evaluations cap-
tured only one point in the life cycle of a health RCS ini-
tiative – only two tracked health RCS longitudinally
[23,24,38]. Similarly, only a few encompassed the contri-
butions of a range of health development efforts, re-
search programs, and RCS initiatives, to the gradual
emergence of a health research system, as has been pos-
sible in case studies taking a longer term view [48].
Directions for evaluation of health RCS
The strengths and weaknesses of the health RCS evalua-
tions which we analyzed likely reflect those in the
broader field of evaluation of research for develop-
ment. Certain development funders are committed to
“strengthening the evidence base for what works or does
not work in international development as well as devel-
oping and strengthening evaluation research capacity
within the UK and internationally” [49]. Where health
RCS is integrated within a research program, an ad-
equate proportion of the program budget should be allo-
cated to quality evaluation, e.g., US federal guidelines
suggest 3% to 5% for evaluation activities [50]. Rigorous
evaluation design could draw on development evaluation
efforts by organizations such as the International Initia-
tive for Impact Evaluation (www.3ieimpact.org) and the
Network of Networks on Impact Evaluation (http://
nonie2011.org/). Building on the mixed methods work
synthesized here, systematic attention to indicator fram-
ing, selection, measurement, and analysis, could occur
while maintaining flexibility and revisiting indicators as
health RCS proceeds [46,51]. We have formulated these
potential directions as a set of recommendations for
which different stakeholders in health RCS could show
leadership (Table 5).
Conclusions
Our research has synthesized new knowledge about
evaluation designs and associated indicators that can be
tracked in different contexts for different health RCS ini-
tiatives, tailored to the particular aims of an initiative.
The use of more rigorous designs and better measure-
ment within clearer evaluation frameworks should pro-
duce the kinds of robust evidence on effectiveness and
impacts that are needed to better justify investments in
health RCS.
Table 5 Recommendations for different stakeholders to improve health RCS evaluation*
Recommendation Funding agencies Priority decision-makers Producers Users Evaluators
International National International
organizations
National
research
councils
Institutions (universities,
research institutes,
NGOs), networks
Researchers
(established
and learning)
International
organizations
National and
sub-national
health services
Adequate allocation of resources to quality
evaluation research alongside investments
in the quality of the science, scientists,
and science communication.
+++ ++ ++
Systematic attention to indicator framing,
selection, measurement (multiple data
sources and valid standards to enhance
quality), and analysis.
+ + ++ ++ + + +++
Development of indicators which better
encompass relationships with knowledge
users.
++ ++ ++ ++ ++ ++ +++
Disaggregation of indicator data according
to equity categories.
+ + ++ ++ ++ ++ +++
Systematic consideration of assumptions,
pre-conditions, or measurement confounders
associated with the evaluations.
++ +++
Greater attention to evaluation design, use of
clear conceptual frameworks, systematic
linkage of indicators in keeping with theories
of change.
+ + ++ +++
Development of comprehensive, prospective
systems for health RCS indicator monitoring
and evaluation, in which long-term impact is
considered throughout the entire project cycle.
++ ++ + + ++ ++ + + ++
Separation out of three components of the
upper level– provincial-national research
environment, international-global research
environment, and research networks.
++ ++ ++ ++ + + + +++
*Role designated as + small, ++ medium, or +++ large.
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